Elder Care

Among heart attack survivors, drug reduces chances of second heart attack or stroke

In a clinical trial involving 18,924 patients from 57 countries who had suffered a recent heart attack or threatened heart attack, researchers have found that the cholesterol-lowering drug alirocumab reduced the chance of having additional heart problems or stroke.

Related posts

Promising treatment for shoulder pain in wheelchair users with spinal cord injury


Advances in deep brain stimulation could lead to new treatments


Eating more plant-based foods may be linked to better heart health